fentanyl has been researched along with Chronic Kidney Failure in 25 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This review evaluates current recommendations for pain management in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) with a specific focus on evidence for opioid analgesia, including the partial agonist, buprenorphine." | 3.96 | Pain management in patients with chronic kidney disease and end-stage kidney disease. ( Dember, LM; Jhamb, M; Liebschutz, J; Roy, PJ; Weltman, M, 2020) |
| "We aim to describe management of a patient receiving renal transplantation for chronic renal failure due to Alport syndrome with low dose of intrathecal bupivacaine and continuous epidural infusion of local anesthetic." | 3.83 | Low-dose Spinal Block With Continuous Epidural Infusion for Renal Transplantation in a Patient With Alport Syndrome: A Case Report. ( Brazzi, L; Bretto, P; Donadio, PP; Gobbi, F; Sales, G, 2016) |
| " Anesthesia was maintained with fentanyl and midazolam." | 3.69 | [The anesthetic management of patients in chronic renal failure for coronary artery bypass surgery without cardiopulmonary bypass]. ( Gotou, K; Hashimoto, Y; Kimura, F; Kimura, N; Wakayama, S, 1997) |
| "He had chronic renal failure and on hemodialysis (HD) for 22 years." | 1.31 | [General anesthesia for a patient on hemodialysis with arteriosclerosis obliterans]. ( Hanaoka, K; Nishiyama, T; Otsuji, M; Yajima, C, 2000) |
| " Though both volume of distribution and elimination half-life increased in the posttransplantation period, only the decrease in clearance was statistically significant." | 1.28 | Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children. ( Brandom, BW; Cook, DR; Davis, JE; Davis, PJ; Scierka, AM; Stiller, RL, 1989) |
| " In a case of end stage renal failure, the pharmacokinetic parameters during cardiac surgery were similar to 18 children from the same age group with normal renal function." | 1.27 | Pharmacokinetics of fentanyl in children with renal disease. ( Crean, P; Goresky, GV; Klein, J; Koren, G; MacLeod, SM, 1984) |
| " The effects of chronic renal failure (CRF) on the pharmacokinetic profile of sufentanil were evaluated in six adolescent patients undergoing renal transplantation, and these findings were compared with data from age-matched control patients with normal renal function who were undergoing other surgical procedures." | 1.27 | Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure. ( Brandom, BW; Cook, DR; Davin-Robinson, KA; Davis, PJ; Stiller, RL, 1988) |
| " These changes, in turn, may result in pharmacokinetic alterations in affected patients." | 1.27 | Pharmacokinetics of sufentanil in patients undergoing renal transplantation. ( Avitable, M; Butt, K; Casthely, PA; Fyman, PN; Moser, F; Reynolds, JR, 1988) |
| " Elimination half-life and plasma clearance were similar in both groups." | 1.27 | Pharmacokinetics of alfentanil in chronic renal failure. ( Chauvin, M; Duvaldestin, P; Lebrault, C; Levron, JC, 1987) |
| "In patients with chronic renal failure, a correlation of probability P less than 0." | 1.26 | Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure. ( Bower, S, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (48.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roy, PJ | 1 |
| Weltman, M | 1 |
| Dember, LM | 1 |
| Liebschutz, J | 1 |
| Jhamb, M | 1 |
| Jun, JH | 1 |
| Kim, GS | 1 |
| Lee, JJ | 1 |
| Ko, JS | 1 |
| Kim, SJ | 1 |
| Jeon, PH | 1 |
| Sen, I | 1 |
| Thomas, S | 1 |
| Arya, VK | 1 |
| Minz, M | 1 |
| Han, J | 1 |
| Saraf, SL | 1 |
| Gordeuk, VR | 1 |
| Gowhari, M | 1 |
| Gobbi, F | 1 |
| Sales, G | 1 |
| Bretto, P | 1 |
| Donadio, PP | 1 |
| Brazzi, L | 1 |
| Honda, A | 1 |
| Arai, T | 1 |
| Akiyama, M | 1 |
| Masuda, E | 1 |
| Kobayashi, M | 1 |
| Hoka, S | 1 |
| Dhir, S | 1 |
| Fuller, J | 1 |
| Koren, G | 1 |
| Crean, P | 1 |
| Goresky, GV | 1 |
| Klein, J | 1 |
| MacLeod, SM | 1 |
| Bower, S | 1 |
| Gramatikova, R | 1 |
| Ianev, Ia | 1 |
| Panchev, P | 1 |
| Vitanova, S | 1 |
| Takita, K | 1 |
| Goda, Y | 1 |
| Kemmotsu, O | 1 |
| Mashio, H | 1 |
| Okuyama, A | 1 |
| Ito, Y | 1 |
| Sakamoto, H | 1 |
| Kawahigashi, H | 1 |
| Kingsley, CP | 1 |
| Chronister, T | 1 |
| Cohen, DJ | 1 |
| Parrish, JM | 1 |
| Drew, R | 1 |
| Bongiovanni, MB | 1 |
| Mercadante, S | 1 |
| Caligara, M | 1 |
| Sapio, M | 1 |
| Serretta, R | 1 |
| Lodi, F | 1 |
| Gotou, K | 1 |
| Kimura, F | 1 |
| Kimura, N | 1 |
| Hashimoto, Y | 1 |
| Wakayama, S | 1 |
| Kurokawa, S | 1 |
| Taga, K | 1 |
| Tobita, T | 1 |
| Kitahara, Y | 1 |
| Fukuda, S | 1 |
| Shimoji, K | 1 |
| Otsuji, M | 1 |
| Nishiyama, T | 1 |
| Yajima, C | 1 |
| Hanaoka, K | 1 |
| Davis, PJ | 2 |
| Stiller, RL | 2 |
| Cook, DR | 2 |
| Brandom, BW | 2 |
| Davis, JE | 1 |
| Scierka, AM | 1 |
| Wiggum, DC | 1 |
| Cork, RC | 1 |
| Weldon, ST | 1 |
| Gandolfi, AJ | 1 |
| Perry, DS | 1 |
| Davin-Robinson, KA | 1 |
| Fyman, PN | 1 |
| Reynolds, JR | 1 |
| Moser, F | 1 |
| Avitable, M | 1 |
| Casthely, PA | 1 |
| Butt, K | 1 |
| Van Peer, A | 1 |
| Vercauteren, M | 1 |
| Noorduin, H | 1 |
| Woestenborghs, R | 1 |
| Heykants, J | 1 |
| Chauvin, M | 1 |
| Lebrault, C | 1 |
| Levron, JC | 1 |
| Duvaldestin, P | 1 |
| Mostert, JW | 2 |
| Evers, JL | 2 |
| Hobika, GH | 2 |
| Moore, RH | 2 |
| Ambrus, JL | 1 |
| Murphy, GP | 1 |
| Kacki, J | 1 |
| Mayzner, E | 1 |
| Zawadzki, A | 1 |
| Siedlecki, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Quadratus Lumborum Block for Analgesia After Living Donor Kidney Transplantation: A Randomized Controlled Trial[NCT04908761] | 88 participants (Actual) | Interventional | 2021-06-03 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fentanyl and Chronic Kidney Failure
| Article | Year |
|---|---|
Preinduction hemodynamic fluctuations in renal transplant recipients--comparison of two combined anesthesia regimens.
Topics: Adolescent; Adult; Allografts; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Local; Bupiva | 2014 |
24 other studies available for fentanyl and Chronic Kidney Failure
| Article | Year |
|---|---|
Pain management in patients with chronic kidney disease and end-stage kidney disease.
Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Hydromorphone; Kidney Failure, Chronic; Oxycodo | 2020 |
Comparison of intrathecal morphine and surgical-site infusion of ropivacaine as adjuncts to intravenous patient-controlled analgesia in living-donor kidney transplant recipients.
Topics: Adult; Aged; Amides; Analgesia, Patient-Controlled; Analgesics, Opioid; Female; Fentanyl; Humans; In | 2017 |
Safety of chronic transdermal fentanyl use in patients receiving hemodialysis.
Topics: Administration, Cutaneous; Adult; Analgesics, Opioid; Female; Fentanyl; Humans; Kidney Failure, Chro | 2016 |
Low-dose Spinal Block With Continuous Epidural Infusion for Renal Transplantation in a Patient With Alport Syndrome: A Case Report.
Topics: Adult; Analgesia, Epidural; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Spinal; Anestheti | 2016 |
Anesthetic management of a patient with a history of Batista procedure for dilated cardiomyopathy undergoing gastric surgery.
Topics: Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Bupivacaine | 2006 |
Case report: pregnancy in hemodialysis-dependent end-stage renal disease: anesthetic considerations.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Intravenous; Anesthetics, Local; | 2007 |
Pharmacokinetics of fentanyl in children with renal disease.
Topics: Anesthesia, Intravenous; Cardiopulmonary Bypass; Child, Preschool; Female; Fentanyl; Humans; Infant; | 1984 |
Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure.
Topics: Adult; Blood Proteins; Female; Fentanyl; Humans; Hyperlipoproteinemias; Kidney Failure, Chronic; Lip | 1982 |
[Anesthesia in creating arteriovenous fistulae in chronic kidney failure patients].
Topics: Adolescent; Adult; Anesthesia; Arteriovenous Shunt, Surgical; Droperidol; Drug Combinations; Female; | 1980 |
Secondary hyperparathyroidism shortens the action of vecuronium in patients with chronic renal failure.
Topics: Anesthesia, Inhalation; Anesthesia, Intravenous; Case-Control Studies; Electromyography; Female; Fen | 1995 |
Case 2--1996. Anesthetic management of a patient with hemoglobin SS disease and mitral insufficiency for mitral valve repair.
Topics: Anemia, Sickle Cell; Anesthesia, Intravenous; Anesthetics, Intravenous; Cardiopulmonary Bypass; Eryt | 1996 |
Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Female; Fentanyl; Humans; Injections, Subcutaneous; Int | 1997 |
[The anesthetic management of patients in chronic renal failure for coronary artery bypass surgery without cardiopulmonary bypass].
Topics: Adult; Anesthesia; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Fentanyl; Human | 1997 |
[Anesthetic management for pericardial fenestration in a hypertrophic cardiomyopathy (HCM) patient with massive pericardial effusion].
Topics: Aged; Anesthesia, Intravenous; Anesthetics, Combined; Anesthetics, Intravenous; Atrial Fibrillation; | 1999 |
[General anesthesia for a patient on hemodialysis with arteriosclerosis obliterans].
Topics: Anesthesia, General; Arteriosclerosis Obliterans; Blood Pressure; Carotid Arteries; Fentanyl; Humans | 2000 |
Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children.
Topics: Adolescent; Alfentanil; Child; Child, Preschool; Cholestasis; Fentanyl; Humans; Infant; Kidney Failu | 1989 |
Postoperative respiratory depression and elevated sufentanil levels in a patient with chronic renal failure.
Topics: Aged; Anesthesia, General; Anesthetics; Fentanyl; Humans; Kidney Failure, Chronic; Kinetics; Male; P | 1985 |
Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure.
Topics: Adolescent; Child; Fentanyl; Half-Life; Humans; Kidney; Kidney Failure, Chronic; Sufentanil | 1988 |
Pharmacokinetics of sufentanil in patients undergoing renal transplantation.
Topics: Adult; Blood Proteins; Fentanyl; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Prot | 1988 |
Alfentanil kinetics in renal insufficiency.
Topics: Adult; Aged; Alfentanil; Analgesics; Female; Fentanyl; Humans; Kidney Failure, Chronic; Kinetics; Ma | 1986 |
Pharmacokinetics of alfentanil in chronic renal failure.
Topics: Adult; Alfentanil; Anesthetics; Blood Proteins; Fentanyl; Glycoproteins; Half-Life; Humans; Injectio | 1987 |
Cardiorespiratory effects of anaesthesia with morphine or fentanyl in chronic renal failure and cerebral toxicity after morphine.
Topics: Anesthesia, Intravenous; Blood Pressure; Blood Volume; Carbon Dioxide; Cardiac Output; Coma; Fentany | 1971 |
Circulatory effects of analgesic and neuroleptic drugs in patients with chronic renal failure undergoing maintenance dialysis.
Topics: Analgesics; Benperidol; Blood Circulation; Blood Pressure; Cardiac Output; Fentanyl; Heart Rate; Hum | 1970 |
Brachial plexus block in uremic patients.
Topics: Anesthesia, Local; Anesthesia, Spinal; Arteriovenous Shunt, Surgical; Axilla; Brachial Plexus; Fenta | 1971 |